RenovoRx
RNXT
9 hedge funds and large institutions have $506K invested in RenovoRx in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, 2 reducing their positions, and 4 closing their positions.
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
13% more funds holding
Funds holding: 8 → 9 (+1)
0.85% less ownership
Funds ownership: 2.02% → 1.17% (-0.85%)
51% less capital invested
Capital invested by funds: $1.02M → $506K (-$518K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$78.4K |
| 2 |
Verition Fund Management
Greenwich,
Connecticut
|
+$61.1K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$26.8K |
| 4 |
CHA
Carmichael Hill & Associates
Gaithersburg,
Maryland
|
+$1.19K |
| 5 |
SIAP
Sterling Investment Advisors (Pennsylvania)
Berwyn,
Pennsylvania
|
+$95 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$157K |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
-$125K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$108K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$73K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$28.6K |
RNXT Hedge Fund Activity: Q4 2021 in Review
9 of the 6,517 institutional investors tracked by Wall St. Rank reported a position in RenovoRx (RNXT) for Q4 2021, worth a combined $506K — down 51% from $1.02M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new RNXT positions and 4 closed out — a net gain of 2 holders — while 0 added to existing stakes and 2 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $78.4K. The largest seller was Cambridge Investment Research Advisors, cutting an estimated $157K.
- 9 institutional investors held RenovoRx (RNXT) as of Q4 2021, up from 8 in Q3 2021.
- Funds reported $506K of RenovoRx stock for Q4 2021, down 51% quarter-over-quarter.
- 6 funds opened new RenovoRx positions in Q4 2021 and 4 closed out, a net change of +2 holders.
- The largest RenovoRx buyer in Q4 2021 was Virtu Financial, an estimated $78.4K added.
- The largest RenovoRx seller in Q4 2021 was Cambridge Investment Research Advisors, an estimated $157K sold.
Based on aggregated 13F filings for Q4 2021.